Quality of Life Claims, Marketing and the FDACreating a Competitive Advantage in a Crowded Market
Product Details
Quality of Life (QoL) claims are worth millions in today’s crowded markets. So why don’t more companies pursue CDER/DDMAC approval? They think gathering the necessary QoL trial data radically increases costs and time to market.
But it doesn’t have to!
Discover how to pump up pipeline profits by designing trials that meet clinical goals and — at the same time — gather data to meet QoL regulatory requirements …
In this 90-minute audio CD/transcript, Todd Clark, an expert on pharmaceutical industry regulation, marketing and economics, will show you surprisingly low-cost secrets for spinning QoL claims into marketing gold.
Drawing on his own exclusive surveys and consulting experience, Todd will reveal exactly what’s required to pass muster with CDER and DDMAC and how to avoid extra trial costs by building in QoL data-gathering right from the start. Plus, from Advair to Zyprexa, you’ll learn how companies have used QoL labeling and marketing to differentiate products — and turbo charge profits.
Order now for your entire team to listen in and discover:
- Why expiring patents and slowing pipelines make QoL tactics a necessity
- What it takes to win approval from the FDA/DDMAC and what missteps (including “implied QoL” claims) to avoid before — and after — approval
- Best-bet products and categories for pursuing QoL claims
- How to design low-cost elements to capture data necessary to make QoL claims
- Real-world best practices for using QoL labeling and marketing to stay visible — and profitable — despite white-hot competition and price pressure
Deliver maximum value for your products and pipeline — Order now to learn secrets for winning and using Quality of Life claims.